These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38442422)

  • 41. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
    Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women.
    Nguyen MN; Nguyen TTH; Pham TDH; Khuu VN; Hoang QC; Nguyen VT; Tran NH
    J Infect Dev Ctries; 2023 Oct; 17(10):1489-1492. PubMed ID: 37956384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of different delivery modes and HBV DNA titers on mother-to-child transmission of hepatitis B.
    Deng TK; Yang P; Liu X; Wang D; Luo H; Zhou J; Xiao X
    Clin Res Hepatol Gastroenterol; 2021 May; 45(3):101542. PubMed ID: 33067171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O; Dim B; Durier C; Nhoueng S; Chhim K; Sovann S; Yom S; Vong C; Yin S; Ros B; Ky V; Pech S; Nem B; Hout K; Guillebaud J; Ear E; Caroupaye-Caroupin L; Rekacewicz C; Fernandez L; Laurent D; Yay C; Kim R; Meyer L; Chhun S;
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
    Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother.
    Wang H; Fang JW; Gu ZW; Song DJ; Chen Y; Chen GD; Zhao B; Sun C; Ma Y; Wang KX; Shen JQ; Yang XF; Luo Q
    J Obstet Gynaecol; 2022 Jul; 42(5):877-882. PubMed ID: 34569426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors associated with Hepatitis B virus infection among pregnant women attending public hospitals in Addis Ababa, Ethiopia.
    Tesfu MA; Habtemariam TT; Belay NB
    PLoS One; 2023; 18(4):e0284646. PubMed ID: 37099607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prevalence of HBsAg, knowledge and practice of hepatitis B prevention among pregnant women in the Limbe and Muyuka Health Districts of the South West region of Cameroon: a three-year retrospective study.
    Eyong EM; Yankam BM; Seraphine E; Ngwa CH; Nkfusai NC; Anye CS; Nfor GK; Cumber SN
    Pan Afr Med J; 2019; 32():122. PubMed ID: 31312290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus.
    Zhao M; Zou H; Chen Y; Zheng S; Duan Z
    J Viral Hepat; 2019 Sep; 26(9):1059-1065. PubMed ID: 31087455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.
    Virine B; Osiowy C; Gao S; Wang T; Castillo E; Martin SR; Lee SS; Simmonds K; van Marle G; Coffin CS
    PLoS One; 2015; 10(10):e0140070. PubMed ID: 26474400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical observation of telbivudine's antiviral efficacy and protection against mother-to-infant transmission of chronic hepatitis B during the first trimester of pregnancy].
    Chen C; Tu X; Cheng Q; Chen F; Dai Y; Gong F; Lin X
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jan; 23(1):9-12. PubMed ID: 25751379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship between hepatitis B virus serum DNA, RNA and quantitative hepatitis B surface antigen, and the predictive value for mother-to-child transmission: an observational cohort study.
    Wang C; Pan YC; Jia ZF; Chi XM; Wang YQ; Yang N; Wu YH; Niu JQ; Jiang J
    BJOG; 2022 Jan; 129(2):241-247. PubMed ID: 34455680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants.
    Pan CQ; Zou HB; Chen Y; Zhang X; Zhang H; Li J; Duan Z
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1349-55. PubMed ID: 23639606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
    Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
    ; Dionne-Odom J; Tita AT; Silverman NS
    Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uptake of perinatal immunoprophylaxis for infants born to women with a record of hepatitis B in Victoria (2009-2017).
    Deng HM; Romero N; Allard N; Rowe S; Yussf N; Cowie B
    Vaccine; 2023 Mar; 41(10):1726-1734. PubMed ID: 36759283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy.
    Liu R; Yang L; Jiang T; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hao H; Hu L; Gao Y; Xu M; Chen X; Yi W; Li M; Xie Y
    Virulence; 2023 Dec; 14(1):2186335. PubMed ID: 36864005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast feeding and immunoprophylaxis efficacy of mother-to-child transmission of hepatitis B virus.
    Zhang L; Gui X; Fan J; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Tong Y; Kong X; Ye P; Zong L
    J Matern Fetal Neonatal Med; 2014 Jan; 27(2):182-6. PubMed ID: 23682864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus.
    Hou J; Cui F; Ding Y; Dou X; Duan Z; Han G; Jia J; Mao Q; Li J; Li Z; Liu Z; Wei L; Xie Q; Yang X; Zhang H; Zhuang H
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):1929-1936.e1. PubMed ID: 30312789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.